Approval · Notice of Compliance 20484 · 2018
ZERIT: Notice of Compliance 20484
Issued February 13, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20484
- Date
- February 13, 2018
- Company
- Bristol-Myers Squibb CanadaSt-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Pm updates to pediatric dosage and administration to reflect discontinuation of the 5 mg capsule and 1 mg/ml powder for oral solution. product labels to meet the pll
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZERIT | Not yet assigned | — |